Management

APAC region to see highest growth rate driven by increased evidence and increasing uptake of low-cost molecular tests

Growth will primarily be driven by increasing affordability, rising healthcare access in India and China, and subsidised…

Use of protein synthesis inhibitors to grow but vaccines will be leading revenue generating drugs

Mergermarket in the global Pharma, Medical & Biotech (PMB) sector report for Q1 –Q4 2016, highlights that total deal values…

According to GBI Research, the prevalence of COPD is expected to increase significantly across the APAC markets as the smoking…

Laurus Labs, post a successful IPO, is embarking on the next phase of its growth, armed with the advantage of its core…

Dr Charu Manaktala, Senior Medical Director & Head of Asia Pacific Biosimilars Centre of Excellence, Strategic Drug…

The strong growth will be primarily driven by the launches of three proprotein convertase subtilisin/ kexin type 9 (PCSK9)…

Pharma companies are embracing the power of digital to further their progress but there is a need for clear strategic direction to…

Amit Mookim, GM, South Asia, QuintilesIMS, explains how digital way will not only benefit the customers but also the overall…